2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Altro …
Orellfuessli.ch Nr. 34928972. Costi di spedizione:, Sofort per Download lieferbar, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.66) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
lehmanns.de Costi di spedizione:Download sofort lieferbar. (EUR 29.95) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
lehmanns.de Costi di spedizione:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
lehmanns.de Costi di spedizione:Download sofort lieferbar. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
lehmanns.de Costi di spedizione:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Altro …
Jean-Louis Prugnaud; Jean-Louis Prugnaud; Jean-Hugues Trouvin; Jean Hugues Trouvin:
Biosimilars - Prima edizione2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
2012
ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
Dati bibliografici del miglior libro corrispondente
Autore: | |
Titolo: | |
ISBN: |
Informazioni dettagliate del libro - Biosimilars
EAN (ISBN-13): 9782817803364
ISBN (ISBN-10): 2817803361
Anno di pubblicazione: 2012
Editore: Springer-Verlag
87 Pagine
Lingua: eng/Englisch
Libro nella banca dati dal 2012-09-27T17:56:33+02:00 (Rome)
Pagina di dettaglio ultima modifica in 2023-03-01T02:27:40+01:00 (Rome)
ISBN/EAN: 9782817803364
ISBN - Stili di scrittura alternativi:
2-8178-0336-1, 978-2-8178-0336-4
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : hugues, jean louis lou
Dati dell'editore
Autore: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Titolo: Biosimilars - A New Generation of Biologics
Editore: Springer; Springer Paris
90 Pagine
Anno di pubblicazione: 2012-11-27
Paris; FR
Stampato / Fatto in
Lingua: Inglese
117,69 € (DE)
142,00 CHF (CH)
Available
XVIII, 90 p.
EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; C; Oncology; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Medicine; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BB
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Altri libri che potrebbero essere simili a questo:
Ultimo libro simile:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< Per archiviare...